Potensi Pleiotropik Kuersetin terhadap Modulasi Fenotipe Makrofag dan Stabilisasi Plak pada Aterosklerosis: Tinjauan Pustaka
- Authors
-
-
- Keywords:
- Array, Array, Array, Array, Array
- Abstract
-
Introduction: Conventional therapy for atherosclerotic plaques focuses on controlling blood lipid levels. However, in patients with comorbid conditions such as diabetes mellitus and chronic kidney disease, plaque progression and rupture continue to proceed aggressively due to the intensification of programmed cell death cascades, namely pyroptosis and ferroptosis, even when LDL levels are normal. First-line statin therapy has a therapeutic gap because it is unable to halt these cell death cascades and carries long-term side effects. Quercetin, a natural flavonoid, emerges as a solution due to its pleiotropic effects. This literature review aims to examine the molecular efficacy of quercetin in restoring vascular endothelial function, modulating macrophage phenotypes, and inhibiting the ferroptosis and pyroptosis cascades to maintain vascular plaque stability. Method: This literature review identified and screened scientific articles published in the last five years from the electronic databases PubMed, ScienceDirect, and Google Scholar that met the inclusion criteria, resulting in seven relevant articles for analysis. Discussion: The results of the literature review indicate that at the endothelial level, quercetin reactivates the KEAP-1/Nrf2/GPX4 axis to suppress free radicals and block ferroptosis. In macrophages, quercetin inhibits the p38MAPK/p16 pathway to prevent cellular senescence and suppresses the NLRP3 inflammasome to inhibit pyroptosis. Furthermore, quercetin stimulates the Stat6/Arg-1 pathway to trigger the polarization of M1 macrophages into pro-resolving M2 macrophages, and suppresses the destructive enzyme MMP-9. These activities increase the thickness of the fibrous cap while improving blood lipid profiles. Conclusion: Quercetin shows strong potential as an adjunct therapy for atherosclerosis through the inhibition of ferroptosis, pyroptosis, and the stabilization of vascular plaques.
- References
-
1. Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, et al. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front Cardiovasc Med 2022;9. https://doi.org/10.3389/FCVM.2022.925923.
2. Chistiakov DA, Bobryshev Y V., Orekhov AN. Macrophage-mediated cholesterol handling in atherosclerosis. J Cell Mol Med 2016;20:17–28. https://doi.org/10.1111/JCMM.12689.
3. Yang Z, Shi J, Chen L, Fu C, Shi D, Qu H. Role of Pyroptosis and Ferroptosis in the Progression of Atherosclerotic Plaques. Front Cell Dev Biol 2022;10:811196. https://doi.org/10.3389/FCELL.2022.811196.
4. Libby P. The changing landscape of atherosclerosis. Nature 2021;592:524–33. https://doi.org/10.1038/S41586-021-03392-8.
5. Yu H, Zhou C, Hu D, Li C, Wang Q, Xue W, et al. Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway. Clin Exp Nephrol 2022;26:640–8. https://doi.org/10.1007/S10157-022-02195-Z.
6. Ward NC, Watts GF, Eckel RH. Statin Toxicity: Mechanistic Insights and Clinical Implications. Circ Res 2019;124:328–50. https://doi.org/10.1161/CIRCRESAHA.118.312782.
7. Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J 2016;37:1720–2. https://doi.org/10.1093/EURHEARTJ/EHW024.
8. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, Inflammation and Immunity. Nutrients 2016;8. https://doi.org/10.3390/NU8030167.
9. LI L, DAI H. Multifaceted regulatory effects of quercetin on cell death pathways: apoptosis, ferroptosis, pyroptosis, and autophagy. SCIENTIA SINICA Vitae 2026. https://doi.org/10.1360/SSV-2025-0117.
10. Luo X, Bao X, Weng X, Bai X, Feng Y, Huang J, et al. The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway. Life Sci 2022;291:120064. https://doi.org/10.1016/J.LFS.2021.120064.
11. Luo G, Xiang L, Xiao L. Quercetin alleviates atherosclerosis by suppressing oxidized LDL-induced senescence in plaque macrophage via inhibiting the p38MAPK/p16 pathway. J Nutr Biochem 2023;116:109314. https://doi.org/10.1016/J.JNUTBIO.2023.109314.
12. Li H, Cao Z, Liu C, Wang Y, Wang L, Tang Y, et al. Quercetin Inhibits Neuronal Pyroptosis and Ferroptosis by Modulating Microglial M1/M2 Polarization in Atherosclerosis. J Agric Food Chem 2024;72:12156–70. https://doi.org/10.1021/ACS.JAFC.4C01134/SUPPL_FILE/JF4C01134_SI_001.PDF.
13. Ermawan R, Pikir BS, Mulyanto M, Utomo B, Widjiati W, Oktaviono YH. Quercetin Stabilizes Atherosclerotic Plaques by Reducing Matrix Metalloproteinase-9 Expression and Enhancing M2 Macrophage Activity in Wistar Rats. The Indonesian Biomedical Journal 2025;17:465–74.
14. Ermawan R, Pikir BS, Mulyanto M. Quercetin Inhibits the Progression of Atherosclerosis by Enhancing the Activity of M2 Macrophages in Wistar Rats. J Trop Life Sci 2025;15:517–26. https://doi.org/10.11594/JTLS.15.03.08.
15. Lv Y, Weng X, Zhu Y, Zhang X, Ma Y, Dai X, et al. Quercetin alleviates postmenopausal atherosclerosis by suppressing endothelial cell ferroptosis via regulating the KEAP1/NRF2/GPX4 signalling pathway. Br J Pharmacol 2026;183:620–43. https://doi.org/10.1111/BPH.70200.
16. Wang L, Han Y, Lei Y, Liu J, Yu J, Li G, et al. Quercetin Induces Macrophage Polarization through PI3K-AKT Pathway in Atherosclerosis: Network Pharmacology, Molecule Docking and in vitro Analysis. IJ Pharmaceutical Research 2026 25:1 2026;25:e168202. https://doi.org/10.5812/IJPR-168202.
17. Ma J, Zhang H, Chen Y, Liu X, Tian J, Shen W. The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis. Biomolecules 2022;12. https://doi.org/10.3390/BIOM12111702.
18. Chen X, Yu C, Kang R, Tang D. Iron Metabolism in Ferroptosis. Front Cell Dev Biol 2020;8:590226. https://doi.org/10.3389/FCELL.2020.590226/XML.
19. Wang L, Cai J, Qiao T, Li K. Ironing out macrophages in atherosclerosis: Ironing out macrophages in atherosclerosis. Acta Biochim Biophys Sin (Shanghai) 2023;55:1. https://doi.org/10.3724/ABBS.2022196.
20. Huang Z, Wu M, Zeng L, Wang D. The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis. Cardiol Res Pract 2022;2022:4287711. https://doi.org/10.1155/2022/4287711.
21. Carpi-Santos R, Calaza KC. Alterations in System xc- Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2. Mol Neurobiol 2018;55:7941–8. https://doi.org/10.1007/S12035-018-0961-8.
22. Green DR. The Coming Decade of Cell Death Research: Five Riddles. Cell 2019;177:1094–107. https://doi.org/10.1016/J.CELL.2019.04.024.
23. Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 2017;171:273. https://doi.org/10.1016/J.CELL.2017.09.021.
24. Luo G, Xiao L, Wang D, Wang N, Luo C, Yang X, et al. Resveratrol attenuates excessive ethanol exposure-induced β-cell senescence in rats: A critical role for the NAD+/SIRT1-p38MAPK/p16 pathway. J Nutr Biochem 2021;89:108568. https://doi.org/10.1016/J.JNUTBIO.2020.108568.
25. Childs BG, Baker DJ, Wijshake T, Conover CA, Campisi J, Van Deursen JM. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science (1979) 2016;354:472–7. https://doi.org/10.1126/SCIENCE.AAF6659/SUPPL_FILE/CHILDS.SM.PDF.
26. Qian Z, Zhao Y, Wan C, Deng Y, Zhuang Y, Xu Y, et al. Pyroptosis in the Initiation and Progression of Atherosclerosis. Front Pharmacol 2021;12. https://doi.org/10.3389/FPHAR.2021.652963.
27. Hoffmann A, Homs Pérez L, Weiss G. Iron as an immunometabolic signal in infection and inflammation. Front Immunol 2026;17:1810718. https://doi.org/10.3389/FIMMU.2026.1810718/XML.
28. Peng J, Li Q, Li K, Zhu L, Lin X, Lin X, et al. Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. J Diabetes Res 2017;2017. https://doi.org/10.1155/2017/3417306.
- Downloads
- Published
- 2026-08-31
- Section
- Article Review
- License
-
Copyright (c) 2026 Muhammad Ardhan Hakim, Muhammad Rifqi Al Azim, Ghazir Rahman Najib

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




